- The trend backdrop is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
HCG
NSI
Week ended 07 Aug 2026
Weekly Investor Report
HealthCare Global Enterprises Limited · Healthcare · Medical Care Facilities
Latest close
675.8 INR
0.7%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 11.8% above the Trend Line and sits at 55.8% of its 52-week range. The latest completed week returned 0.7%, after a 1.4% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 50/100.
Setup score
54
out of 100
Latest Close
675.8 INR
7 Aug 2026
1W Return
0.7%
latest completed week
4W Return
1.4%
short-term follow-through
12W Return
6.1%
quarterly tape
Trend Breadth
50.0%
26 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- No major top-level risk cluster is currently dominant.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.7%
Latest completed week; four-week move 1.4%.
Indicator stack
41/75
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
23 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 11.8% above the Trend Line and sits at 55.8% of its 52-week range. The latest completed week returned 0.7%, after a 1.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7412-week average 0.45
12-week confirmation
Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.74Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.4% over four weeks, 6.1% over 12 weeks, and 9.5% over one year. The current trend has remained active for 4 consecutive weeks.
Performance by holding period
Active trend streak4 weeks
Active weeks in one year26
Trend breadth50.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.13Latest activity-pressure read.
Pressure change56.8%Four-week change in activity pressure.
Leadership5.94Latest relative-leadership reading.
RS change-16.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength25/100Blend of value, momentum, and quality. Underlying universe rank 76; rank 1 is best.
Value12/100Relative valuation strength. Underlying universe rank 89; rank 1 is best.
Quality65/100Profitability and accounting quality. Underlying universe rank 36; rank 1 is best.
Momentum72/100Medium-term price momentum. Underlying universe rank 29; rank 1 is best.
Growth21/100Revenue and earnings growth. Underlying universe rank 80; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework14/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 733.3x Price divided by trailing earnings.
- Price / sales
- 4.0x Market value relative to trailing revenue.
- EV / EBITDA
- 25.4x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 0.5% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 51.1% Gross profit retained from each unit of revenue.
- Operating margin
- 8.7% Operating profit retained from revenue.
- Free-cash-flow margin
- 2.2% Free cash flow generated from revenue.
- Return on invested capital
- 6.6% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 14.4% Latest one-year revenue growth.
- EPS growth
- -70.9% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -49.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -4.4% Net share repurchases relative to market value.
- Shareholder yield
- -4.4% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.7x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 23 relevant articles.
1 positive · 22 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-16.0%Distance below the 52-week high.
13-week volatility3.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+9.1%Week of 3 Jul.
Worst week-3.1%Week of 19 Jun.
Latest week+0.7%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains11
Flat weeks0
Modest losses11
Sharp losses0
Recent vol3.3%13-week weekly-return volatility.
Base vol3.2%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Healthcare
4-week rank43 / 100
Group average1.2%
Trend breadth83.0%
Trend83.0%active weekly trend signals
MD85.0%positive activity pressure
RS73.0%positive relative leadership
Four-week leaders
IndustryIN Medical Care Facilities
4-week rank11 / 21
Group average2.1%
Trend breadth85.7%
Trend85.7%active weekly trend signals
MD76.2%positive activity pressure
RS61.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape54/100
Trend, activity pressure, participation, and risk combine to a 54/100 tape read.
Indicator analysis69/100Latest 12-week confirmation: trend 4/12, activity pressure 12/12, relative leadership 11/12.
Activity pressure 0.74; No reversal markers Factors42/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 89; Small Cap Core rank 93 SVQF14/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1358.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 23 relevant articles.
S&P 500 Companies' Quarterly Earnings Growth Eases Amid Healthcare Drop, Oppenheimer Says Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 675.8 INR | 0.7% | 604.6 INR | 503.1 INR | 1.13 | 5.94 | 790.3K | On |
| 31 Jul 2026 | 671.3 INR | 0.7% | 603.4 INR | 500.9 INR | 1.25 | 6.21 | 531.8K | On |
| 24 Jul 2026 | 666.5 INR | 1.6% | 602.8 INR | 498.8 INR | 1.19 | 8.40 | 855.3K | On |
| 17 Jul 2026 | 655.8 INR | -1.6% | 603.0 INR | 496.6 INR | 0.97 | 4.57 | 2.2M | On |
| 10 Jul 2026 | 666.4 INR | 1.8% | 604.7 INR | 494.5 INR | 0.72 | 7.12 | 1.4M | Off |
| 3 Jul 2026 | 654.8 INR | 9.1% | 606.3 INR | 492.3 INR | 0.47 | 5.40 | 114.9K | Off |
| 26 Jun 2026 | 600.4 INR | -1.7% | 608.5 INR | 490.2 INR | 0.43 | -2.15 | 0 | Off |
| 19 Jun 2026 | 611.0 INR | -3.1% | 612.8 INR | 488.4 INR | 0.57 | 0.03 | 240.5K | Off |
| 12 Jun 2026 | 630.5 INR | -0.9% | 616.6 INR | 486.5 INR | 0.82 | 5.26 | 140.5K | Off |
| 5 Jun 2026 | 636.0 INR | -0.2% | 620.3 INR | 484.5 INR | 0.97 | 7.71 | 108.6K | Off |
| 29 May 2026 | 637.2 INR | -2.6% | 624.4 INR | 482.4 INR | 1.01 | 7.52 | 822.3K | Off |
| 22 May 2026 | 654.3 INR | 2.7% | 628.0 INR | 480.4 INR | 0.78 | 10.03 | 1.7M | Off |
| 15 May 2026 | 637.2 INR | 5.5% | 631.5 INR | 478.1 INR | 0.35 | 7.80 | 986.2K | Off |
| 8 May 2026 | 603.8 INR | 5.5% | 634.7 INR | 476.0 INR | -0.05 | 0.15 | 839.1K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.